基线表达c-Myc定义了致癌性K-Ras的组织特异性
bioRxiv : the preprint server for biology
|August 8, 2025
概括
瘤性KRAS突变在癌症中很常见,但具有组织特异性. 低c-Myc水平阻止激活的K-Ras影响细胞健康,揭示了瘤基因组织特异性的关键机制.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 克拉斯是癌症中经常发生突变的癌基因.
- 克拉斯突变表现出组织特异性流行,需要对潜在机制进行研究.
- 了解瘤基因组织特异性对于向癌症治疗至关重要.
研究的目的:
- 研究KRAS瘤基因组织特异性的分子机制.
- 确定影响细胞对激活K-Ras.反应的因素.
- 为了确定KRAS驱动的癌症的潜在治疗点.
主要方法:
- 利用了带有条件瘤基因Kras等位基因的基因工程小鼠模型.
- 在成年老鼠组织中表达激活的K-Ras (K-Ras G12D).
- 评估K-Ras G12D对细胞健康和信号通路的影响,包括c-Myc和MAPK.
主要成果:
- 激活的K-Ras (K-Ras G12D) 细胞健身效应独立于正规的MAPK信号传递.
- 低基线c-Myc表达使组织对瘤性K-Ras.不宽容.
- 肝脏内外c-Myc表达逆转了非容许状态.
- 组织对瘤性K-Ras的宽容性独立于增殖率,细胞循环停止或细胞亡.
结论:
- 基底c-Myc水平是KRAS癌基因特异性的关键决定因素.
- 组织内在的信号网络,特别是c-Myc表达,决定了对瘤性KRAS的反应.
- 这些发现为针对KRAS突变瘤的向癌症治疗开发提供了洞察力.
相关概念视频
The Ras Gene
6.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.4K
Induced Pluripotent Stem Cells
4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.4K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
MAPK Signaling Cascades
6.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.1K
Small GTPases - Ras and Rho
4.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.2K
Cancer-Critical Genes I: Proto-oncogenes
9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K


